Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Merzon

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohortAriel Israel, Eugene Merzon, Alejandro A Schäffer, et al.
Vaccines|May 28, 2022
Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster VaccinationAriel Israel, Eugene Merzon, Yotam Shenhar, et al.
Vaccines|January 22, 2022
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 InfectionAriel Israel, Yotam Shenhar, Ilan Green, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infectionAriel Israel, Yotam Shenhar, Ilan Green, et al.
BMJ (Clinical Research Ed.)|November 25, 2021
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design studyAriel Israel, Eugene Merzon, Alejandro A Schäffer, et al.
Vaccines|January 22, 2022
The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based StudyEugene Merzon, Ilan Green, Eli Somekh, et al.
BMC Health Services Research|May 9, 2023
Patient-level predictors of temporal regularity of primary care visitsAdam J Rose, Wiessam Abu Ahmad, Faige Spolter, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depressionAri Lauden, Akim Geishin, Eugene Merzon, et al.
BMJ Mental Health|April 20, 2025
Increased prevalence of urticarial diseases and antihistamine/corticosteroid consumption in patients with attention-deficit/hyperactivity disorderEli Magen, Eugene Merzon, Akim Geishin, et al.
Brain, Behavior, & Immunity - Health|September 10, 2024
High rates of mood disorders in patients with chronic idiopathic eosinopeniaEli Magen, Akim Geishin, Abraham Weizman, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohortAriel Israel, Eugene Merzon, Alejandro A Schäffer, et al.
Vaccines|May 28, 2022
Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster VaccinationAriel Israel, Eugene Merzon, Yotam Shenhar, et al.
Vaccines|January 22, 2022
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 InfectionAriel Israel, Yotam Shenhar, Ilan Green, et al.
Medrxiv : the Preprint Server for Health Sciences|August 31, 2021
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infectionAriel Israel, Yotam Shenhar, Ilan Green, et al.
BMJ (Clinical Research Ed.)|November 25, 2021
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design studyAriel Israel, Eugene Merzon, Alejandro A Schäffer, et al.
Vaccines|January 22, 2022
The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based StudyEugene Merzon, Ilan Green, Eli Somekh, et al.
BMC Health Services Research|May 9, 2023
Patient-level predictors of temporal regularity of primary care visitsAdam J Rose, Wiessam Abu Ahmad, Faige Spolter, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depressionAri Lauden, Akim Geishin, Eugene Merzon, et al.
BMJ Mental Health|April 20, 2025
Increased prevalence of urticarial diseases and antihistamine/corticosteroid consumption in patients with attention-deficit/hyperactivity disorderEli Magen, Eugene Merzon, Akim Geishin, et al.
Brain, Behavior, & Immunity - Health|September 10, 2024
High rates of mood disorders in patients with chronic idiopathic eosinopeniaEli Magen, Akim Geishin, Abraham Weizman, et al.
Pageof 12